Market revenue in 2022 | USD 3.3 million |
Market revenue in 2030 | USD 9.9 million |
Growth rate | 14.9% (CAGR from 2022 to 2030) |
Largest segment | Stem cells |
Fastest growing segment | Other Products |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stem cells, Other Products |
Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 51.52% in 2022. Horizon Databook has segmented the Australia veterinary regenerative medicine market based on stem cells, other products covering the revenue growth of each sub-segment from 2018 to 2030.
Due to the local presence of universities, such as Pet Universe Veterinary Centre, the country's market is anticipated to grow steadily. For instance, Medivet, the high-yield Medivet Adipose SC Kits manufacturer, chose Pet Universe as its first regional stem cell processing and therapy center in South Australia.
This form of regenerative medicine can treat aging and degenerative conditions in large and small animals, such as arthritic dogs or cats, whose quality of life has declined due to pain and limited mobility. A proprietary LED technology filters and activates tissue extracted from the animal's fatty tissue. The patient is then given this activated tissue to hasten the recovery of injured ligaments, joints, and cartilage caused by illness, degeneration, or injury.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia veterinary regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into Australia veterinary regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account